First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
Izalontamab brengitecan (iza-bren) is an antibody-drug conjugate and bispecific antibody undergoing evaluation in small cell ...
SAN JUAN, Puerto Rico -- The investigational antibody-drug conjugate sacituzumab tirumotecan plus pembrolizumab (Keytruda) ...
Clinical Trials Arena on MSN
BioNTech and DualityBio report positive data for trastuzumab pamirtecan
The Phase II cohort analysis included 145 patients whose conditions had progressed following initial chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results